Lanreotide Acetate | CAS:127984-74-1

We serve Lanreotide Acetate CAS:127984-74-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Lanreotide Acetate

Chemical Name:Lanreotide Acetate
CAS.NO:127984-74-1
Synonyms:Lanreotide Acetate
Somatuline
 
Physical and Chemical Properties:
Molecular Formula C56H73N11O12S2
Molecular Weight 1156.375
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Lanreotide Acetate is a drug used in the control and prevention of glycemia and hypoglycemic brain damage without surgery in patients diagnosed with congenital hyperinsulinism. It improves outcomes in patients suffering from acromegalyresulting from invasive pituitary macroadenoma.



Contact us for information like Lanreotide Acetate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Somatuline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Somatuline Use and application,Somatuline technical grade,usp/ep/jp grade.


Related News: More serious cases could lead to potentially deadly conditions such as pneumonia and kidney failure, with the former having been reported among some patients in China.dAMP manufacturer It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.9-bromo-11,11-dimethylbenzo[a]fluorene supplier It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing.1-Bromo-3,5-difluorobenzene vendor They have also voiced frustrations about patients from mainland China hiding their travel and medical history, potentially endangering other patients.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.